CXCL12 and neoplasm: Gao demonstrated that triptolide has the ability to reshape the immune microenvironment of colon cancer, and its main mechanism is to reduce tumor-associated macrophage infiltration and M2 polarization by inhibiting tumor-derived CXCL12 [23].